A Study on Antioxidants status in Type 2 Diabetes Mellitus Patients
DOI:
https://doi.org/10.7439/ijbar.v7i6.3371Abstract
Background: Diabetes mellitus is an endocrinal disorder. Over production of reactive oxygen and nitrogen species thought to be involved in the initiation and development of vascular complications in diabetes. Increased levels of MDA, Vitamin E and Ceruloplasmin are the markers for oxidative stress in type 2 diabetes mellitus. The aim of the present study is to study the Antioxidant status in Type 2 Diabetes patients. Materials and Methods: This, case control study was conducted on 40 subjects. Among them 20 were controls, 20 were known Type 2 Diabetes patients. Patients with T2DM with other endocrinal disorders, patients on antioxidants, minerals and multivitamins as supplement form are excluded from the study. A laboratory investigations consisting of glucose, total cholesterol, triglycerides, HDLC, LDLC Vitamin E, MDA and Ceruloplasmin were carried out on fasting blood sample of subjects selected for this study. Results: In the present study, FBS, PPBS, MDA, Ceruloplasmin, total cholesterol and LDLC were significantly increased in T2DM cases and HDLC, Vitamin E was significantly decreased in cases when compared to controls. ( p value 0.05). Conclusion: The findings of this study is in accordance to earlier studies, that there is an increased oxidative stress in diabetics compared to controls; and the oxidative stress further increases as diabetes to cardiovascular diseases. This study emphasizes the importance of assessing the antioxidant status in diabetes in addition to the markers of oxidative stress and lipid profile to formulate the specific therapies for early therapeutic intervention and better treatment of diabetes mellitus.Downloads
References
V. Mohan, S. Sandeep, R. Deepa, B. Shah & C. Varghese, Epidemiology of type 2 diabetes: Indian scenario. Diabetes Indian Journal of Medical Research. 2007; 125: 217-230.
Sunitha S, Gandham Rajeev, Wilma Delphine Silvia CR and Soniya Rao, Evaluation of Significance of Liver Enzymes as Screening Tests for the Early Detection of Clinically Asymptomatic Non Alcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus Patients. International Journal of Biomedical and Advance Research 2015; 6(12): 860-863.
Joslins. Diabetes Mellitus, 14th edition (2005).
Kannel, WB and McGee, DL, Diabetes and cardiovascular disease: The Framingham study. Journal of American Medical Association. 1979; 241:2035-2038.
Stamler J, Vaccaro O, Neaton JD and Wentworth D, The multiple risk factor intervention trail research group: Diabetes other risk factors and 12 year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 1993; 16: 434-444.
Wagenkneeht LE, Bowden DW, Carr JJ, Langefeld CD, Freedman BJ, and Rich SS, Familial aggregation of coronary artery calcium in families with type 2 diabetes. Diabetes. 2001; 50:861-866.
Jakus V, The role of free radicals, oxidative stress and antioxidant system in diabetic vascular disease. Bratislava Medical Journal. 2000; 101(10):541-551.
Halliwell B and M. Whitemen, Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? British Journal of Pharmacology. 2004; 142:231-255.
Halliwell B, Role of free radicals in the neurodegenerative diseases: therapeutic implications on antioxidant treatment. Drugs and Aging. 2001; 18:685-716.
Donnel D, R. Raniere, C. Roberto, G. Daniela and M. Aldo, Biomarkers of oxidative damage in human disease. Clinical Chemistry. 2006; 52:601-623.
Pasupathi P, Govindasamy, Bakthavathasalam, Saravanan G and Latha R, Evaluation of oxidative stress and antioxidant status in patients with diabetes mellitus. Journal of Applied Sciences Research 2009; 5(7):770-775.
Kuyvenhoren JP and AE Meinders, Oxidative stress and diabetes mellitus pathogenesis of long term complications. EJIM. 1999; 10:9
Ramachandran B, Ravi K, Narayanan V, Kardaswamy M and Subramanian S, Effect of macrocyclic binuclear oxovanadium complex on tissue defence system in streptozocin-induced diabetic rats. Clinica Chimica Acts. 2004; 345:141-150.
Uzel N, Sivas A, Uysal M and OZH, Erythrocyte lipid peroxidation and glutathione peroxidase activities in patients with diabetes mellitus. Hormone and Metabolic Research. 1987; 19:89-90.
Gallou G, Ruelland A, Legras B, Maugendre D, Allannic H and Cloarec, Plasma malondialdehyde in type 1 and type 2 diabetes patients. Clin Chem Acta. 1993; 214:227-234.
Aydin A, Orhan H, Sayal A, Ozata M, Sahin G and Isimer A, Oxidative stress and nitric oxide related parameters in type 2 diabetes mellitus: Effects of glycemic control. Clin. Biol. Chem.2001; 34:65-70.
Seghrouchni I, Dral J and Bannier E, Oxidative stress parameters in type 1, type 2 and insulin treated type 2 diabetes mellitus; insulin treatment efficiency. Clin. Chem. Acta. 2002; 321:89-96.
Madhur G and Suresh C, Proxidant and Antioxidant Status in Patients of Type II Diabetes Mellitus with IHD. Indian Journal of Clinical Biochemistry 2006; 21 (2): 118-122.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
How to Cite
